Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
This section ranks key world stock indices and explains the metrics behind rankings, helping readers compare market breadth.
22,503 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
For dividend kings long-term investors, a disciplined, income-forward approach can power wealth over two decades. Thi...
A new mega-listing grabbed headlines by raising $26.5 billion, ranking just below SpaceX in U.S. market history. Read...
Mortgage rates hovering near 5% are shifting the math for buyers and investors alike. This guide breaks down what a r...
Tariff shocks can rattle markets, but some energy stocks offer steadier cash flows through regulated pricing and long...
When oil surges grab the headlines, it’s easy to assume inflation will follow. In reality, inflation data often reass...
When a trusted income vehicle slumps by half, the question isn’t just about yield—it’s about safety, value, and the b...
VCR is down about 9% year-to-date, but nearly 40% of its holdings sit in Amazon and Tesla, reshaping the fund’s risk ...
Sea's Q1 2026 earnings call will reveal how the company balances growth with profitability across its three businesse...
As markets wobble in 2026, investors favor a two-bucket plan that locks in $5,000 in monthly income and preserves cap...
Private equity is moving from wall street legends to the everyday investor. Here’s how cathie wood's private equity i...
A decades‑long pause in U.S. nuclear construction has reshaped the investment landscape, rewarding a utility with a l...